ASTH — Astrana Health Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	17.7	122	49.3	50.5	57.8
Depreciation
Deferred Taxes
Non-Cash Items	6.82	-98.7	29.6	31.3	21.3
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-22.8	10.8	-20.1	-9.58	-16.2
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	13.7	46.2	70.3	82.1	68.2
Capital Expenditures	-1.04	-1.16	-19.2	-22.9	-28.5
Purchase of Fixed Assets
Other Investing Cash Flow Items	-180	96.7	35.8	15.8	-37
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-181	95.5	16.5	-7.11	-65.5
Financing Cash Flow Items	-5.74	-1.04	-2.15	-4.61	-5.01
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	163	-51.7	-47.7	-20.1	3.42
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3.63	90	39.1	54.9	6.13